Project ID	Sample origin	No. of Participants	Participant Condition	Pathogen	Time of Sample Collection	Time of Antibody Isolation	Antigen Used	Gate	Sort Date	Data Access	Comment
PREMISE-00	USA	13	Convalescent	SARS-CoV-2	March 2020 - Jan 2021	17-38 days post symptoms onset	WA1 	Memory B cells (CD3-CD8-CD56-CD14-CD16-CD19+CD20+IgGorIgA+IgM-) double positive	April - May 2021	https://doi.org/10.1038/s41467-022-35456-2	Supplementary 6
PREMISE-00	USA	13	Convalescent	SARS-CoV-2	March 2020 - Jan 2021	17-38 days post symptoms onset	S2P	Memory B cells (CD3-CD8-CD56-CD14-CD16-CD19+CD20+IgGorIgA+IgM-) double positive	April - May 2021	https://doi.org/10.1038/s41467-022-35456-2	Supplementary 6
PREMISE-00	USA	13	Convalescent	SARS-CoV-2	March 2020 - Jan 2021	17-38 days post symptoms onset	RBD 	Memory B cells (CD3-CD8-CD56-CD14-CD16-CD19+CD20+IgGorIgA+IgM-) double positive	April - May 2021	https://doi.org/10.1038/s41467-022-35456-2	Supplementary 6
PREMISE-00	USA	13	Convalescent	SARS-CoV-2	March 2020 - Jan 2021	17-38 days post symptoms onset	NTD	Memory B cells (CD3-CD8-CD56-CD14-CD16-CD19+CD20+IgGorIgA+IgM-) double positive	April - May 2021	https://doi.org/10.1038/s41467-022-35456-2	Supplementary 6
PREMISE-CCHF-122			Vaccination	CCHF	Jan-24	2 weeks post vaccination		Np+	May-24	Some Zeonod link	